Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors

被引:21
作者
Abe, M
Akiyama, T
Umezawa, Y
Yamamoto, K
Nagai, M
Yamazaki, H
Ichikawa, Y
Muraoka, Y
机构
[1] Microbial Chem Res Ctr, Shinagawa Ku, Tokyo 1410021, Japan
[2] Nippon Kayaku Co Ltd, Div Res & Dev, Pharmaceut Grp, Kita Ku, Tokyo 1158588, Japan
关键词
sulphostin analogues; dipeptidyl peptidase IV inhibitors; structure-activity relationships;
D O I
10.1016/j.bmc.2004.10.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structure of sulphostin (1). a novel dipeptidyl peptidase IV (DPP-IV) inhibitor, is consisted of three key functional groups, including a characteristic amino(sulfoamino)phosphinyl group, on a piperidine ring. To examine the relationship between its structure and the inhibitory activity against DPP-IV. various analogues were synthesized and their activities were investitlaied- These results indicated that all of the functional groups on the piperidine ring were crucial to the DPP-IV inhibitory activity of sulphostin. and that the sulfonic acid group, which constructed the amino(sulfoamino)phosphinyl group, contributed to the stability of the compound. Moreover, those functional groups should be adjoined on the piperidine ring for the inhibitory acivity. The size of the nitrogen-containing heterocyclic ring including piperidine appeared to scarcely affect the activity. In the present study, the sulfonic acid-deficient five-membered ring analogue 27a showed the strongest inhibitory activity (IC50 = 11 nM). (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:785 / 797
页数:13
相关论文
共 23 条
[1]   First synthesis and determination of the absolute configuration of sulphostin, a novel inhibitor of dipeptidyl peptidase IV [J].
Abe, M ;
Akiyama, T ;
Nakamura, H ;
Kojima, F ;
Harada, S ;
Muraoka, Y .
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (06) :999-1004
[2]   Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes [J].
Ahrén, B ;
Simonsson, E ;
Larsson, H ;
Landin-Olsson, M ;
Torgeirsson, H ;
Jansson, PA ;
Sandqvist, M ;
Båvenholm, P ;
Efendic, S ;
Eriksson, JW ;
Dickinson, S ;
Holmes, D .
DIABETES CARE, 2002, 25 (05) :869-875
[3]   Sulphostin, a potent inhibitor for dipeptidyl peptidase IV from Streptomyces sp MK251-43F3 [J].
Akiyama, T ;
Abe, M ;
Harada, S ;
Kojima, F ;
Sawa, R ;
Takahashi, Y ;
Naganawa, H ;
Homma, Y ;
Hamada, M ;
Yamaguchi, A ;
Aoyagi, T ;
Muraoka, Y ;
Takeuchi, T .
JOURNAL OF ANTIBIOTICS, 2001, 54 (09) :744-746
[4]  
Augustyns K, 1999, CURR MED CHEM, V6, P311
[5]   Pyrrolidides: Synthesis and structure-activity relationship as inhibitors of dipeptidyl peptidase IV [J].
Augustyns, KJL ;
Lambeir, AM ;
Borloo, M ;
DeMeester, I ;
Vedernikova, I ;
Vanhoof, G ;
Hendriks, D ;
Scharpe, S ;
Haemers, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (04) :301-309
[6]   Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats [J].
Balkan, B ;
Kwasnik, L ;
Miserendino, R ;
Holst, JJ ;
Li, X .
DIABETOLOGIA, 1999, 42 (11) :1324-1331
[7]   Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors [J].
Belyaev, A ;
Zhang, XM ;
Augustyns, K ;
Lambeir, AM ;
De Meester, I ;
Vedernikova, I ;
Scharpé, S ;
Haemers, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (06) :1041-1052
[8]  
BRISTOL LA, 1992, J IMMUNOL, V149, P367
[9]   Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV .1. Variation of the P-2 position of X(aa)-boroPro dipeptides [J].
Coutts, SJ ;
Kelly, TA ;
Snow, RJ ;
Kennedy, CA ;
Barton, RW ;
Adams, J ;
Krolikowski, DA ;
Freeman, DM ;
Campbell, SJ ;
Ksiazek, JF ;
Bachovchin, WW .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (10) :2087-2094
[10]   CD26, let it cut or cut it down [J].
De Meester, I ;
Korom, S ;
Van Damme, J ;
Scharpé, S .
IMMUNOLOGY TODAY, 1999, 20 (08) :367-375